Therapeutic Solutions International (Therapeutic Solutions International) FCF Margin % : -858.33% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Therapeutic Solutions International FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Therapeutic Solutions International's Free Cash Flow for the three months ended in Dec. 2023 was $-0.21 Mil. Therapeutic Solutions International's Revenue for the three months ended in Dec. 2023 was $0.02 Mil. Therefore, Therapeutic Solutions International's FCF Margin % for the quarter that ended in Dec. 2023 was -858.33%.

As of today, Therapeutic Solutions International's current FCF Yield % is -49.88%.

The historical rank and industry rank for Therapeutic Solutions International's FCF Margin % or its related term are showing as below:

TSOI' s FCF Margin % Range Over the Past 10 Years
Min: -18600 Med: -1151.85 Max: -501.45
Current: -1065.66

During the past 13 years, the highest FCF Margin % of Therapeutic Solutions International was -501.45%. The lowest was -18600.00%. And the median was -1151.85%.

TSOI's FCF Margin % is ranked worse than
76.75% of 1041 companies
in the Biotechnology industry
Industry Median: -141.21 vs TSOI: -1065.66

Therapeutic Solutions International FCF Margin % Historical Data

The historical data trend for Therapeutic Solutions International's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Therapeutic Solutions International FCF Margin % Chart

Therapeutic Solutions International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,151.85

-1,060.32

-671.23

-501.45

-1,081.82

Therapeutic Solutions International Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-4,277.78	-873.91	-1,296.15	-1,196.15	-858.33

Competitive Comparison of Therapeutic Solutions International's FCF Margin %

For the Biotechnology subindustry, Therapeutic Solutions International's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Therapeutic Solutions International's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Therapeutic Solutions International's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Therapeutic Solutions International's FCF Margin % falls into.

Therapeutic Solutions International FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Therapeutic Solutions International's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1.071	/	0.099
	=	-1,081.82 %

Therapeutic Solutions International's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.206	/	0.024
	=	-858.33 %

Therapeutic Solutions International FCF Margin % Related Terms

Thank you for viewing the detailed overview of Therapeutic Solutions International's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Therapeutic Solutions International (Therapeutic Solutions International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Therapeutic Solutions International Inc (OTCPK:TSOI) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

701 Wild Rose Lane, Elk City, ID, USA, 83525

Website

https://www.therapeuticsolutionsint.com

Therapeutic Solutions International Inc focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces nutraceuticals. Its current product, QuadraMune, is a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone. Cellular Division obtained exclusive rights to a patented adult stem cell for the development of therapeutics in the area of chronic traumatic encephalopathy (CTE) and traumatic brain injury (TBI) and Lung Pathology (LP).

Executives

Thomas Ichim	director	211 E. OSBORN RD, PHOENIX AZ 85012
Gerry B Berg	officer: CFO	1658 AVENIDA LA POSTA, ENCINITAS CA 92024
Timothy G Dixon	director, officer: Chairman, President, CEO	4093 OCEANSIDE BLVD., SUITE B, OCEANSIDE CA 92056
Barry Glassman	officer: VP, Training & Education	2051 ELBOW LANE, ALLENTOWN PA 18103
James P Boyd	director, 10 percent owner	PO BOX 2145, RANCHO SANTA FE CA 92067